MENS Earnings Date: Nov 20, 2026 (Estimated) — Jyong Biotech Ltd. Ordinary Shares
NASDAQ · Healthcare · Biotechnology
Updated
When is MENS's next earnings date?
Jyong Biotech Ltd. Ordinary Shares (MENS) is expected to report H1 2026 earnings on Friday, November 20, 2026 at 9:27 AM ET (before market open); the date is an estimate and has not been confirmed by the company.
How did MENS do in its last earnings report?
In its most recent report on May 15, 2026 (FY 2025), Jyong Biotech Ltd. Ordinary Shares posted EPS of -$0.06. Revenue was $0. The stock's 1-day post-earnings move was -3.4%.
About Jyong Biotech Ltd. Ordinary Shares
Jyong Biotech Ltd. is a Taiwanese biotechnology enterprise dedicated to the research, development, and market introduction of botanical therapeutics, specifically aimed at addressing diseases of the urinary system. Its operations are orchestrated through various subsidiary entities, including Health Ever Bio-Tech and Genvace. The company is actively advancing a robust pipeline of drug candidates, which notably features MCS-2, currently undergoing Phase III trials for benign prostatic hyperplasia (BPH); PCP, which is in Phase II development for prostate cancer; and IC, presently in pre-clinical stages.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | FY 2025 | — | -0.06 | — | $0 | — | -3.37% | +0.00% | -23.08% |
Showing last 1 quarters.